1Chambers LA.Characteristics and clinical application of blood filters.Transfusion Sci,1989,10:207-210.
2Andersen O.Theoretical risk of vCJD transmission via blood transfusion. Leukocyte and erythrocyte depletion of the transfusion blood is a practice in many countries.Lakartidningen,2002,99:1310-1314.
3Rossi EC,Simon TL,Moss GS,et al.Principles of Transfusion Medicine.Baltimore,2nd edition,Williams & Wilkins.1996:353-374.
4Pennington J,Taylor GP,Sutherland J,et al.Persistence of HTLV-I in blood components after leukocyte depletion.Blood,2002,100:677-681.
6Olivencia Yurvati AH,Ferrara CA,Tierney N,et al.Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass.Perfusion,2003,18(Ssuppl 1):23-31.
7Baksaas ST,Videm V,Mollnes TE,et al.Effects on complement, granulocytes and platelets of a leukocyte-depletion filter during in vitro extracorporeal circulation.Scand Cardiovasc J,1997,31:73-77.
9Matheis G,Scholz M,Simon A,et al.Timing of luekocyte filtration during cardiopulmonary bypass.Perfusion,2001,16(Suppl):31-37.
10Edelman MJ,Potter P,Mahaffey KG,et al.The potential for reintroduction of tumor cells during intraoperative blood salvage:reduction of risk with use of the RC-400 leukocyte depletion filter.Urology,1996,47:179～181.
10Olivencia Yurvati A H, Ferrara C A, Tiierney N, et al. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status postcardiopulmonary bypass [J]. Perfusion, 2003,18 (Ssuppl 1 ) : 23-31.
